Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Alternative splicing of the human glucocorticoid receptor (hGR) pre-mRNA generates two highly homologous isoforms, termed hGR alpha and hGR beta. hGR alpha is a ligand-activated transcription factor which, in the hormone-bound state, modulates the expression of glucocorticoid-responsive genes by binding to specific glucocorticoid response element (GRE) DNA sequences. In contrast, hGR beta does not bind glucocorticoids and is transcriptionally inactive. We demonstrate here that hGR beta is able to inhibit the effects of hormone-activated hGR alpha on a glucocorticoid-responsive reporter gene in a concentration-dependent manner. [3H]-Dexamethasone binding studies indicate that hGR beta does not alter the affinity of hGR alpha for its hormonal ligand. The presence of hGR beta in nuclear extracts and its ability to bind to a radiolabeled GRE oligonucleotide suggest that its inhibitory effect may be due to competition for GRE target sites. Reverse transcription-PCR analysis shows expression of hGR beta mRNA in multiple human tissues. These results indicate that hGR beta may be a physiologically and pathophysiologically relevant endogenous inhibitor of glucocorticoid action, which may participate in defining the sensitivity of target tissues to glucocorticoids. They also underline the importance of distinguishing between the two receptor isoforms in all future studies of hGR function and the need to revisit old data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These GR variants are derived from a single gene by alternative splicing and alternative translation initiation mechanisms.”
From Corticosteroids (2016) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Exon 2 forms the N-terminal domain of GR, exon 3–4 constitute the central DBD, while exons 5–9 code for the hinge and ligand-binding domain.”
From Corticosteroids (2016) · cites this paper as [43]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Alternative splicing at exon 9 of primary GR transcript generates two highly homologous mRNA transcripts that results in the production of two GR isoforms termed GRα and GRβ (Fig.3A)43, 44.”
From Corticosteroids (2016) · cites this paper as [43]
In the citing paper
“The conventional belief that glucocorticoids act through a single GR protein has changed dramatically with the discovery of a diverse collection of receptor isoforms.”
From Corticosteroids (2016) · cites this paper as [43]
In the citing paper
“The GR protein is encoded by the Nr3c1 gene and consists of 9 exons; exon 1 forms the 5’-untranslated region, while exon 2–9 code for the GR protein.”
From Corticosteroids (2016) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439 · cited 1×
“receptor complex with other DNA elements and/or nuclear proteins then modulate the rate at which these genes are transcribed (6-8).”
BackgroundLipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,978
Schreiber, E., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179 · cited 1×
“48 h after transfection, cells were washed twice with PBS, and nuclear extracts were prepared essentially as described elsewhere (18).”
MethodThe Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Self-citationSTEROID RECEPTOR REGULATED TRANSCRIPTION OF SPECIFIC GENES AND GENE NETWORKS
Yamamoto, K. R. (1985) · Annual Review of Genetics · doi:10.1146/annurev.ge.19.120185.001233 · Cited by 1,872
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869 · cited 3×
“This difference renders hGRJ3 unable to bind glucocorticoid hormones and to be transcriptionally active (9, 11-14).”
BackgroundJonat, C., Rahmsdorf, H. J., Park, K.-K., Cato, A. C. B., Gebel, S., Ponta, H., & Herrlich, P. (1990) · Cell · doi:10.1016/0092-8674(90)90395-u · Cited by 1,566 · cited 1×
“Formation of non-GRE/DNA-binding complexes with the glucocorticoid receptor is believed to be the predominant mechanism by which previously described inhibitors of glucocorticoid action, such as c-jun (23-25), calreticulin (26, 27), and”
BackgroundYang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553
Functional inactivation of genes by dominant negative mutations
Herskowitz, I. (1987) · Nature · doi:10.1038/329219a0 · Cited by 1,160 · cited 1×
“its transcriptionally active counterpart, and, therefore, fits the definition of a dominant negative inhibitor of hGRa (20).”
Background
Cited by
Items 401–500 of 640
Weikkolainen, K., Keski‐Oja, J., & Koli, K. M. (2003) · Growth Factors · doi:10.1080/08977198310001598778 · Cited by 18
Lee, C., Lee, E. Y., Cho, Y. S., Moon, K. A., Yoo, B., & Moon, H. (2005) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2005.20.2.146 · Cited by 18
Structure and Function of the Steroid and Nuclear Receptor Ligand Binding Domain
Simons, S. S. (1998) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-1764-0_3 · Cited by 19
Adrenal insufficiency in sepsis
Polito, A., Aboab, J., & Annane, D. (2006) · Revista Brasileira de Terapia Intensiva · doi:10.1590/s0103-507x2006000100014 · Cited by 19
Glucocorticoids: Molecular Mechanisms of Action
Cruz‐Topete, D., & Cidlowski, J. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-77658-3_11 · Cited by 20
Glucocorticoid and mineralocorticoid receptor expression in critical illness: A narrative review
Vassiliou, A. G., Athanasiou, N., Vassiliadi, D. A., Jahaj, E., Keskinidou, C., Kotanidou, Α., & Dimopoulou, I. (2021) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v10.i4.102 · Cited by 21
Parks, L. L., Turney, M. K., Detera‐Wadleigh, S. D., & Kovacs, W. J. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00107-5 · Cited by 17
Advances in the development of genetic markers for the diagnosis of disease and drug response
Halapi, E. C., & Hakonarson, H. H. (2002) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2.5.411 · Cited by 17
New Insights into the Pathogenesis and Management of Steroid-Resistant Asthma
Spahn, J. D., Leung, D. Y. M., & Szefler, S. J. (1997) · Journal of Asthma · doi:10.3109/02770909709068188 · Cited by 18
Vassiliadi, D. A., Vassiliou, A. G., Ilias, Ι., Tsagarakis, S., Kotanidou, Α., & Dimopoulou, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111473 · Cited by 18
Phenotypical alterations induced by glucocorticoids resistance in RPMI 8226 human myeloma cells
Genty, V., Dine, G., & Dufer, J. (2003) · Leukemia Research · doi:10.1016/j.leukres.2003.08.009 · Cited by 20
Gong, W., Chávez, S., & Beato, M. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.10.9991 · Cited by 16
Molecular mechanisms of glucocorticoid resistance
Bantel, H., Domschke, W., & Schulze‐Osthoff, K. (2000) · Gastroenterology · doi:10.1053/gast.2000.19224 · Cited by 16
Nicolaides, N. C., Charmandari, E., & Chrousos, G. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95740-4 · Cited by 17
Self-citationKolb, K. L., Mira, A. L. S., Auer, E. D., Bucco, I. D. O., Silva, C. E. D. L. E., dos Santos, P. I., Hoch, V. B.-B., Oliveira, L. C., Hauser, A. B., Hundt, J. E., et al. (2023) · Genes · doi:10.3390/genes14091805 · Cited by 18
“GR β inhibits the transcriptional activity of GR α through yet poorly understood mechanisms, probably through the formation of inactive heterodimers with GR α , or competition for binding on GREs or binding with coactivators [63–65].”
Zinkhan, E. K., Yu, B., Callaway, C. W., & McKnight, R. A. (2018) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174418000016 · Cited by 19
“Glucocorticoid signaling induces transcription of proadipogenic factors through activation of GR isoforms, including active GR isoform (GR-α).(40,41) Binding of glucocorticoid to GR-α induces transcription of proadipogenic and lipogenic factors, such as ATP-binding cassette sub-family A member 1 (Abca1).”
BackgroundCharacterization of Oryzias latipes glucocorticoid receptors and their unique response to progestins
Miyagawa, S., Lange, A., Tohyama, S., Ogino, Y., Mizutani, T., Kobayashi, T., Tatarazako, N., Tyler, C. R., & Iguchi, T. (2014) · Journal of Applied Toxicology · doi:10.1002/jat.3020 · Cited by 15
“In mammals, GR has two isoforms namely GRα and GRβ, and GRβ contains a truncated LBD, and acts as a dominant counter response for the Wiley & Sons, Ltd. activation of GRα (Bamberger et al., 1995; Oakley et al., 1996).”
BackgroundThe Glucocorticoid Domain in the Lung and Mechanisms of Action
Ballard, P. L. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-014-8_1 · Cited by 16
Takami, S., Wong, Z. Y. H., Stebbing, M. S., & Harrap, S. B. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.4.h1379 · Cited by 16
“The mechanism of insensitivity under these circumstances is unknown but may include the formation of alternative splicing of GRL pre-RNA (3).”
BackgroundThe human glucocorticoid receptor
Nicolaides, N. C., & Chrousos, G. P. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2023.06.005 · Cited by 17
Self-citationExpression of glucocorticoid receptor isoforms in human adrenocortical adenomas
Boyle, B., Butz, H., Likó, I., Zalatnai, A., Tóth, M., Feldman, K., Horanyi, J., Igaz, P., Rácz, K., & Patócs, A. (2010) · Steroids · doi:10.1016/j.steroids.2010.04.008 · Cited by 16
Pharmacogenetics of Inflammatory Bowel Disease: A Focus on Crohn’S Disease
Rufini, S., Ciccacci, C., Novelli, G., & Borgiani, P. (2017) · Pharmacogenomics · doi:10.2217/pgs-2017-0068 · Cited by 16
Mohammed, S., Mahdi, F., Sulochana, S. P., & Paris, J. J. (2021) · Viruses · doi:10.3390/v13050813 · Cited by 14
DIAGNOSIS AND MANAGEMENT OF STEROID-RESISTANT ASTHMA
Leung, D. Y. M., & Szefler, S. J. (1997) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70405-6 · Cited by 14
Current trends in the diagnosis and treatment of autoimmune hepatitis in Japan
Ohira, H., & Takahashi, A. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00904.x · Cited by 14
Molecular Mechanisms of Glucocorticoid Action
Bloom, J. W. (2001) · Lung biology in health and disease · doi:10.1201/b14023-9 · Cited by 13
Poupouzas, G. I., Lotsios, N. S., Vrettou, C. S., Issaris, V., Keskinidou, C., Papavassiliou, K. A., Halioti, A., Botoula, E., Tzanela, M., Papavassiliou, A. G., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05628-9 · Cited by 12
“GCR-α is the active isoform that binds to glucocorticoids (GCs) and regulates the transcription of anti-inflammatory genes, whereas GCR-β, which does not bind GCs, can inhibit GCR-α function by acting as a dominant-negative regulator [3–5].”
The Hypothalamic-Pituitary-Adrenal Axis in Human Health and Disease
Nicolaides, N. C., Charmandari, E., & Chrousos, G. P. (2014) · Springer eBooks · doi:10.1007/978-3-319-08798-6_6 · Cited by 16
Self-citationThe Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas
Regazzo, D., Mondin, A., Scaroni, C. M., Occhi, G., & Barbot, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126469 · Cited by 15
“GRβ instead, while initially considered purely an inhibitor of the transcription factor activity of GRα [11], is now recognized as having intrinsic activities in inflammatory processes, insulin signaling, cell communication, and tumorigenesis in a GRα-independent manner (see [12] for a more comprehensive review).”
BackgroundIlias, Ι., Vassiliou, A. G., Keskinidou, C., Vrettou, C. S., Orfanos, S. E., Kotanidou, Α., & Dimopoulou, I. (2023) · Biomedicines · doi:10.3390/biomedicines11071801 · Cited by 19
Exploring the nexus of nuclear receptors in hematological malignancies
Manickasamy, M. K., Sajeev, A., BharathwajChetty, B., Alqahtani, M. S., Abbas, M. A. E., Hegde, M., Aswani, B. S., Shakibaei, M., Sethi, G., & Kunnumakkara, A. B. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05085-z · Cited by 12
Genomic and non-genomic effects of glucocorticoids
Тодосенко, Н. М., Koroleva, Y. A., Хазиахматова, О. Г., Yurova, K. A., & Litvinova, L. S. (2017) · Genes and Cells · doi:10.23868/201703003 · Cited by 13
Korn, S. H., Thunnissen, E., Wesseling, G., Arends, J., & Wouters, E. F. �. (1998) · Respiratory Medicine · doi:10.1016/s0954-6111(98)90402-4 · Cited by 12
Min, J., Perera, L., Krahn, J. M., Jewell, C. M., Moon, A. F., Cidlowski, J. A., & Pedersen, L. C. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00453-17 · Cited by 16
“In contrast, the unique 15-amino-acid C terminus of hGR hypothetically renders it unable to bind glucocorticoid agonists such as DEX (15, 18, 19), though the structural mechanism for this loss of function is currently unknown.”
BackgroundDuma, D., & Cidlowski, J. A. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.039 · Cited by 11
The role of glucocorticoid receptor (GR) polymorphisms in human erythropoiesis.
Varricchio, L., & Migliaccio, A. R. (2014) · Europe PMC (PubMed Central) · Cited by 17
Glucocorticoid Resistance in Inflammatory Diseases
Franchimont, D. P., & Chrousos, G. P. (2007) · Neuroimmune biology · doi:10.1016/s1567-7443(07)00218-9 · Cited by 11
Self-citationGlucocorticoids and the emerging importance of T cell subsets in steroid refractory diseases
Schewitz‐Bowers, L. P., Lee, R., Dayan, C. M., & Dick, A. D. (2008) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923970802334848 · Cited by 13
“Predominantly found in the nucleus (independent of hormone), GR has an intact DNA binding domain and can bind GREs.((17,62,63)) Overall, GR accounts for 0.”
BackgroundInfluentialMacPhee, I. A. M., Fredericks, S., & Holt, D. W. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.15.2593 · Cited by 11
“The hGRα receptor is responsible for glucocorticoid activity and hGRβ does not bind glucocorticoids, but competes for binding to glucocorticoid response elements with resultant antagonism of glucocorticoid effects [83].”
BackgroundZhao, Z., Xue, Y., Hong, D., Zhang, H., Hu, Z., Fan, S., & Chen, H. (2017) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2016.0260 · Cited by 12
“The GR consists of a hormone-binding domain, a DNA-binding domain, and an amino terminal region, and contains two spliceosomes, GRa and GRb (Bamberger et al., 1995).”
Inhibition of cGMP-dependent protein kinase II by its own splice isoform
Gambaryan, S. P., Palmetshofer, A., Glazova, M. V., Smolenski, A., Kristjansson, G. I., Zimmer, M., & Lohmann, S. M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00412-6 · Cited by 11
Stress and Critical Illness: The Integrated Immune/Hypothalamic-Pituitary-Adrenal Axis Response
Torpy, D. J., & Chrousos, G. P. (1997) · Journal of Intensive Care Medicine · doi:10.1177/088506669701200503 · Cited by 12
Self-citationAm, H., Aa, S. V. E., Wenting, M. J. G., Lafeber, F. P. J. G., van Reesema, D. R. S., Jacobs, J. W. G., & Bijlsma, J. W. J. (2003) · PubMed · Cited by 10
A novel human glucocorticoid receptor SNP results in increased transactivation potential
Green, T. L., Tung, K. L., Lim, D., Leventhal, S. M., Cho, K., & Greenhalgh, D. G. (2016) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2016.12.003 · Cited by 12
Marlier, L. N. J. L., Patacchioli, F. R., Porzio, O., Chiusaroli, R., Borboni, P., Lauro, R., & Angelucci, L. (1997) · Journal of Molecular Neuroscience · doi:10.1007/bf02789390 · Cited by 10
“Other studies have also reported in humans the existence of GR isoforms, although the situation still remains to be clarified for rat ( Bamberger et al., 1995; Oakley et al., 1996).”
BackgroundHirano, T., Horigome, A., Oka, K., Takeuchi, H., Yoshida, M., SAKURAI, E., Kozaki, K., Matsuno, N., Nagao, T., & Kozaki, M. (1997) · Immunopharmacology · doi:10.1016/s0162-3109(96)00163-4 · Cited by 10
Berth‐Jones, J. (2016) · Wiley eBooks · doi:10.1002/9781118441213.rtd0018 · Cited by 11
Noortgate, M. V. D., Eede, F. V. D., Coppens, V., Giltay, E. J., Picker, L. D., & Morrens, M. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.100965 · Cited by 12
Glucocorticoid receptor epigenetic activity in the heart
Akinborewa, O., & Quattrocelli, M. (2025) · Epigenetics · doi:10.1080/15592294.2025.2468113 · Cited by 12
“While GRβ works as a negative regulator, GRα - the ‘main’ GR isoform – is broadly expressed and exerts the glucocorticoid-dependent transcription factor function [33–35].”
Engert, L. C., Weiler, U., Stefanski, V., & Schmucker, S. S. (2017) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2017.04.004 · Cited by 13
“This protein isoform of the GR does not bind glucocorticoids and acts as an inhibitor of GRa, the transcriptionally active isoform [38].”
BackgroundNozaki, M., Haraguchi, S., Miyazaki, T., Shigeta, D., Kano, N., Lei, X., Kim‐Kaneyama, J., Minakata, H., Miyazaki, A., & Tsutsui, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-20226-2 · Cited by 11
Nagy, Z., Ács, B., Butz, H., Feldman, K., Márta, A., Szabó, P. M., Baghy, K., Pázmány, T., Rácz, K., Likó, I., et al. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.10.006 · Cited by 9
Bivol, S., Owen, S., & Rose’Meyer, R. B. (2016) · Reproduction Fertility and Development · doi:10.1071/rd15356 · Cited by 14
“Because GRb exerts a dominant negative effect on the functional potential of GRa (Bamberger et al. 1995; Oakley et al. 1996, 1999a), GCinduced localisation of the b isoform of the GR to the nucleus may have contributed to the modulation of GC responsiveness in male and SGA fetuses.”
BackgroundGlucocorticoid Receptor Expression in Nontumorous Human Pituitaries and Pituitary Adenomas
Kovács, K., Rotondo, F., Ştefăneanu, L., Fereidooni, F., Horváth, É., Lloyd, R. V., & Scheithauer, B. W. (2000) · Endocrine Pathology · doi:10.1385/ep:11:3:267 · Cited by 9
Solari, V., & Puri, P. (2002) · Journal of Pediatric Surgery · doi:10.1053/jpsu.2002.32260 · Cited by 9
The glucocorticoid receptor: expression, function, and regulation of glucocorticoid responsiveness
Oakley, R. H., & Cidlowski, J. A. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8348-1_4 · Cited by 10
Glucocorticoids: Biochemical Group That Play Key Role in Fetal Programming of Adult Disease
Mohammed, A. (2012) · InTech eBooks · doi:10.5772/50798 · Cited by 9
“However, GR- has no such ability to bind to GCs but its main role thought to be inhibitory to GR- action by competitive interference on the GRE target sites (28).”
BackgroundLi, J., Niu, J., Ou, S., Ye, Z.-Y., Liu, D., Wang, F., Su, Y., & Wang, J. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1201-y · Cited by 8
Glucocorticoid sensitivity in Behçet's disease
Quax, R. A. M., van Laar, J. A. M., van Heerebeek, R., Greiner, K., Ben‐Chetrit, E., Stanford, M. R., Wallace, G. R., Fortune, F., Ghabra, M., Soylu, M., et al. (2012) · Endocrine Connections · doi:10.1530/ec-12-0056 · Cited by 8
Gene therapy to bet on: protecting neurons from stress hormones
AKAMA, K., & MCEWEN, B. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.02.004 · Cited by 8
Role of Th17-cell related cytokines in geriatric asthma
Zhang, Q., Xu, X., Li, Y., & Zhaojia, S. (2018) · Journal of International Medical Research · doi:10.1177/0300060518803828 · Cited by 8
“GR-b functions as a dominant negative inhibitor of GRa-mediated transactivation.(22,23) How cytokines play a role in the pathogenesis of geriatric patients with asthma is unclear.”
BackgroundSpika, I., Hammer, S., Kleuser, B., Körting, H. C., & Schäfer‐Korting, M. (2003) · Skin Pharmacology and Physiology · doi:10.1159/000069754 · Cited by 8
Knight, S. R., & Morris, P. J. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3343-1.50019-0 · Cited by 8
Berth‐Jones, J. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch73 · Cited by 14
Nicolaides, N. C., & Chrousos, G. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813814-4.00028-6 · Cited by 9
Self-citationFrezza, G., Colli, L. M., de Antônio, S. R., & de Castro, M. (2014) · Transplant Immunology · doi:10.1016/j.trim.2014.04.002 · Cited by 7
“Therefore, we cannot rule out an overexpression of GC receptor β (GRβ), a dominant negative inhibitor of GRα [2], inducing GC insensitivity in CKD.”
BackgroundSweet-P inhibition of glucocorticoid receptor β as a potential cancer therapy
Nwaneri, A. C., McBeth, L., & Hinds, T. D. (2016) · Cancer Cell & Microenvironment · doi:10.14800/ccm.1362 · Cited by 7
Gatica, H., Aliste, M., Guerrero, J., & Goecke, I. A. (2011) · Rheumatology · doi:10.1093/rheumatology/ker126 · Cited by 8
Population Genomics of Drug Response
Halapi, E. C., Stefánsson, K., & Hakonarson, H. H. (2004) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200404020-00002 · Cited by 7
Schofield, J. P. R., Strazzeri, F., Bigler, J., Boedigheimer, M., Adcock, I. M., Chung, K. F., Bansal, A., Knowles, R. G., Dahlen, S.-E., Wheelock, C. E., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/516328 · Cited by 7
Chen, X., & He, H. (2025) · Hormone and Metabolic Research · doi:10.1055/a-2619-5035 · Cited by 7
“Reporter gene experiments showed that hGRβ alone did not influence luciferase activity stimulated by dex - amethasone [12].”
Different levels of various glucocorticoid-regulated genes in corticotroph adenomas
Evang, J. A., Bollerslev, J., Casar‐Borota, O., Lekva, T., Ramm‐Pettersen, J., & Berg, J. P. (2013) · Endocrine · doi:10.1007/s12020-012-9871-0 · Cited by 7
“The alpha isoform of the glucocorticoid receptor (GR) is a transcription factor that is fundamental for most of the known biological actions of glucocorticoids [10].”
BackgroundGlucocorticoid receptor expression and cortisol level in cord blood of term infants
Imamura, T., Sato, M., Hashimoto, K., Ishii, T., Goto, A., Go, H., Kawarada, T., Kawasaki, Y., Momoi, N., Ujiie, N., et al. (2011) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2010.548885 · Cited by 6
“Whereas GRalpha exerts GC effects, GRbeta has a dominant negative effect on hormone-induced GR action [6,7].”
BackgroundOnnis, V., Kinsella, G. K., Carta, G., Fayne, D., & Lloyd, D. G. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.21 · Cited by 6
Yung, K. C., Xu, C. W., Zhang, Z. W., Yu, W. J., Li, Q., Xu, X. R., Han, Y. F., Wang, X. J., & Yin, J. (2020) · Hematology · doi:10.1080/16078454.2019.1710025 · Cited by 6
Pharmacology of Glucocorticoids: An Overview
Gravanis, A., & Margioris, A. N. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-101-5_4 · Cited by 6
Flood, L., Innala, E., Löfberg, R., & Wikström, A. C. (2007) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2007.10.002 · Cited by 6
Vasiliadi, D., Gratsias, Y., Tsagarakis, S., Botoula, E., Trivizas, P., Thalassinos, N., & Moutsatsou, P. (2002) · HORMONES · doi:10.14310/horm.2002.1172 · Cited by 7
Bleecker, J. D., Paepe, B. D., Vervaet, V. L., Arys, B., Creus, K. K., Werbrouck, B. F., & Martin, J. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2006.11.004 · Cited by 6
“GCRb lacks the steroid binding domain [3] and has been shown in transfection studies to be a dominant negative inhibitor of GCRa [4,5], although other studies have challenged this presumption [6].”
ResultThe Glucocorticoid Receptor β-Isoform: A Perspective on Its Relevance in Human Health and Disease
Schaaf, M. J. M., & Cidlowski, J. A. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_12 · Cited by 7
Prise en charge d’une rectocolite hémorragique sévère ou corticorésistante
Carbonnel, F. (2007) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(07)89399-7 · Cited by 5
“Une étude portant sur 23 malades en poussée de RCH (dont 12 corticorésistants) indique que l’expression du RNA du GR-β dans les cellules mononucléées du sang est retrouvée chez 10/12 malades corticorésistants et 1/11 malades corticosensibles [22].”
InfluentialAssociations of Chinese social face with cortisol level and glucocorticoid receptor gene
Gong, P., Guo, W., Zhang, X., Cao, K., Wang, Q., Zhang, M., Liu, J., Fan, Y., Zhang, R., & Zhou, X. (2021) · Current Psychology · doi:10.1007/s12144-020-01255-5 · Cited by 6
Gallo, M. T., Dolci, B., Fumagalli, F., Brivio, P., & Calabrese, F. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00856 · Cited by 6
Orbak, Z. (2006) · Biochemistry (Moscow) · doi:10.1134/s0006297906100038 · Cited by 7
Luisa, R.-P. A., & Alejandro, M. F. M. (2011) · InTech eBooks · doi:10.5772/17632 · Cited by 7
“Recently a splice variant of GR, termed GR-b, has been identified that does not bind glucocorticoids but binds to DNA and may therefore potentially interfere with the action of glucocorticoids (Bamberger et al., 1995).”
BackgroundMerkulov, V. M., & Merkulova, T. I. (2012) · Russian Journal of Genetics Applied Research · doi:10.1134/s2079059712030070 · Cited by 7
“GRβ mRNA as well as GRα mRNA is found everywhere (Bamberger et al., 1995; Oakley et al., 1996), although it is detected at a significantly lower level.”
BackgroundExpression of Glucocorticoid Receptors in the Regenerating Human Skeletal Muscle
Filipović, D., Pirkmajer, S., Miš, K., Marš, T., & Grubič, Z. (2011) · Physiological Research · doi:10.33549/physiolres.932171 · Cited by 6
Lipopolysaccharide Stress Induces Cryptic Exon Splice Variants of the Human Glucocorticoid Receptor
Green, T. L., Leventhal, S. M., Lim, D., Cho, K., & Greenhalgh, D. G. (2019) · Shock · doi:10.1097/shk.0000000000001318 · Cited by 6
“hGRß lacks a functional ligand binding domain; however, it can still dimerize with hGRa, the major reference isoform, and thereby impede its function (17, 18, 28).”
Backgroundα and β glucocorticoid receptor mRNA expressionin skeletal muscle
Korn, S. H., Lang, E. K.-D., Engel, G. E. J., Arends, J., Wouters, E. F. �., & Thunnissen, E. (1998) · Journal of Muscle Research and Cell Motility · doi:10.1023/a:1005439118259 · Cited by 5
“Because of the known inhibitory function of the b on the a GR form (Bamberger et al., 1995; Oakley et al., 1996), it is also important to take a/b GR ratios into consideration in studying these responses.”
BackgroundThe Effects of Social Experience on the Stress System and Immune Function in Nonhuman Primates
Kohn, J. N., Panagiotakopoulos, L., & Neigh, G. N. (2016) · Developments in primatology · doi:10.1007/978-3-319-30872-2_4 · Cited by 8
Barnes, P. J. (1998) · Elsevier eBooks · doi:10.1016/b978-012079027-2/50122-2 · Cited by 5
Plisov, S. Y., Poirot, M., Modarress, K. J., Cavanaugh, A. H., Edwards, D. P., & Simons, S. S. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00118-6 · Cited by 5
“Considerable functional heterogeneity has also been observed among glucocorticoid receptors, even though only one of the two receptor sequences has been described to bind steroid [52, 53].”
BackgroundSouthwestern Internal Medicine Conference: Syndromes of Severe Asthma
Weissler, J. C. (2000) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200003000-00006 · Cited by 6
Kaplan, N. M., Palmer, B. F., & Weissler, J. C. (2000) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40715-3 · Cited by 5
Corticosteroid insensitivity in obese asthma: potential mechanisms and therapeutic perspectives
To, M., & To, Y. (2025) · Frontiers in Allergy · doi:10.3389/falgy.2025.1719900 · Cited by 5
Lotsios, N. S., Vrettou, C. S., Poupouzas, G. I., Chalioti, A., Keskinidou, C., Pratikaki, M. E., Giannopoulou, V., Kotanidou, Α., Vassiliadi, D. A., Dimopoulou, I., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1414785 · Cited by 6
Effect of dexamethasone on expression of glucocorticoid receptor in human monocyte cell line THP-1
Bo, L., Xiangjun, B., & Haiping, W. (2006) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/bf02828029 · Cited by 4
Glucocorticoid Resistance in the Upper Respiratory Airways
Fabiana, C. P., Tamashiro, E., & Wilma, T. (2012) · InTech eBooks · doi:10.5772/53105 · Cited by 5
“Some authors have shown that, when overexpressed, GR inhibits the effect of GR on both transactivation and on AP-1 and NF-κB repression [49-51].”
BackgroundStaphylococcus aureus in atopic dermatitis
Leung, D. Y. M. (2008) · Series in dermatological treatment · doi:10.3109/9780203091449.005 · Cited by 4
Aravilli, R. K., Vikram, S. L., & Kohila, V. (2020) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666201001142416 · Cited by 4
Metadata
- Authors
- Bamberger, C. M., Bamberger, A. M., de Castro, M., & Chrousos, G. P.
- Affiliations
- National Institutes of Health (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1995-06-01
- Volume
- 95
- Issue
- 6
- Pages
- 2435-2441
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC295915
- OpenAlex
- W1974791065
- Cited by
- 642
- References
- 41
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 9 · 2023: 13 · 2022: 6 · 2021: 13 · 2020: 7 · 2019: 25 · 2018: 21 · 2017: 18 · 2016: 23 · 2015: 21 · 2014: 15 · 2013: 16 · 2012: 18
- FWCI
- 15.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- glucocorticoid receptor beta, glucocorticoid receptor alpha, alternative splicing, receptor isoforms, glucocorticoid response element, transcriptional repression, dexamethasone binding, glucocorticoid sensitivity
- MeSH terms
- Animals, Base Sequence, Cells, Cultured, Chlorocebus aethiops, Dexamethasone, DNA-Binding Proteins, Glucocorticoids, Humans, Molecular Sequence Data, Receptors, Glucocorticoid, Recombinant Proteins, Regulatory Sequences, Nucleic Acid, RNA, Messenger, Transcription, Genetic, Gene Expression, Alternative Splicing, DNA Primers, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.